Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Urocit®-K safely and effectively. See full prescribing information for Urocit®-K. Urocit®-K (Potassium Citrate) Extended-release tablets for oral use Initial U.S. Approval: 1985
Medication labelWhy this: Advisory · dailymed-prescription
Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies (14.1)]. Potassium citrate is indicated for the management of Hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies (14.2)]. Potassium citrate is indicated for the management of Uric acid lithiasis with or without calcium stones [see Clinical Studies (14.3) ].
- generic_name
- potassium citrate
- product_names
- potassium citrate
- ndc
- 54868-4779, 0178-0610, 54868-4779-0, 54868-4779-1, 54868-4779-2, 54868-6176, 0178-0615, 54868-6176-0, 54868-6176-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en